FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:576-578 February 25, 1993 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In many areas of the United States the battle against tuberculosis is being lost. Two major markers of this failure are the increasing incidence of tuberculosis and the rising prevalence of drug-resistant tuberculous infection. The recent epidemics of multidrug-resistant tuberculosis in several East Coast hospitals and an explosive outbreak in the New York state prison system have taken well in excess of 100 lives^1,2. Since 1985, after 35 years of steadily declining incidence (with declines averaging 6 percent per year), tuberculosis case rates have increased each year. Direct and indirect epidemiologic data indicate that the human immunodeficiency virus (HIV) . . . [Full Text of this Article]

Directly Observed Therapy

Intermittent Regimens

Getting the Job Done

References

Related Letters:

Directly Observed Treatment of Tuberculosis
Hotchkiss R. L., DiFerdinando G. T., Klein S. J., Novick L. F., Perlman D. C., Salomon N., Iseman M. D., Cohn D. L., Sbarbaro J. A.
Extract | Full Text  
N Engl J Med 1993; 329:135-136, Jul 8, 1993. Correspondence

This article has been cited by other articles:

• Griffith, D. E. (2004). Treatment of Multidrug-resistant Tuberculosis: Should You Try This at Home?. Am. J. Respir. Crit. Care Med. 169: 1082-1083 [Full Text]  
• Hollender, E. S., Ashkin, D., Narita, M. (2003). Urine Color Test to Monitor Isoniazid Compliance: "Pissin' in the Wind"?. Chest 123: 668-670 [Full Text]  
• Richards III, E. P. (2002). Public Health Law: Power, Duty, Restraint. JAMA 287: 246-248 [Full Text]  
• Narita, M., Alonso, P., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., Ashkin, D. (2001). Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994-1997. Chest 120: 343-348 [Abstract] [Full Text]  
• Laserson, K. F., Iademarco, M. F. (2000). Profiling Drug Resistance in Immigrants With Tuberculosis. Chest 117: 623-625 [Full Text]  
• SNYDER, D. C., CHIN, D. P. (1999). Cost-effectiveness Analysis of Directly Observed Therapy for Patients with Tuberculosis at Low Risk for Treatment Default. Am. J. Respir. Crit. Care Med. 160: 582-586 [Abstract] [Full Text]  
• Chaulk, C. P., Kazandjian, V. A., for the Public Health Tuberculosis Guidelines Pane, (1998). Directly Observed Therapy for Treatment Completion of Pulmonary Tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA 279: 943-948 [Abstract] [Full Text]  
• Singleton, L., Turner, M., Haskal, R., Etkind, S., Tricarico, M., Nardell, E. (1997). Long-term Hospitalization for Tuberculosis Control: Experience With a Medical-Psychosocial Inpatient Unit. JAMA 278: 838-842 [Abstract]  
• Pulido, F., Pena, J.-M., Rubio, R., Moreno, S., Gonzalez, J., Guijarro, C., Costa, J.-R., Vazquez, J.-J. (1997). Relapse of Tuberculosis After Treatment in Human Immunodeficiency Virus--Infected Patients. Arch Intern Med 157: 227-232 [Abstract]  
• De Cock, K. M., Binkin, N. J., Zuber, P. L. F., Tappero, J. W., Castro, K. G. (1996). Research Issues Involving HIV-Associated Tuberculosis in Resource-Poor Countries. JAMA 276: 1502-1507 [Abstract]  
• Pablos-Mendez, A., Sterling, T. R., Frieden, T. R. (1996). The Relationship Between Delayed or Incomplete Treatment and All-Cause Mortality in Patients With Tuberculosis. JAMA 276: 1223-1228 [Abstract]  
• Chaulk, C. P., Moore-Rice, K., Rizzo, R., Chaisson, R. E. (1995). Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis. JAMA 274: 945-951 [Abstract]  
• Brown, R. E., Miller, B., Taylor, W. R., Palmer, C., Bosco, L., Nicola, R. M., Zelinger, J., Simpson, K. (1995). Health-Care Expenditures for Tuberculosis in the United States. Arch Intern Med 155: 1595-1600 [Abstract]  
• Barclay, D. M. III, Richardson, J. P., Fredman, L. (1995). Tuberculosis in the Homeless. Arch Fam Med 4: 541-546 [Abstract]  
• McAnulty, J. M., Fleming, D. W., Hawley, M. A., Baron, R. C. (1995). Missed Opportunities for Tuberculosis Prevention. Arch Intern Med 155: 713-716 [Abstract]  
• Concato, J., Rom, W. N. (1994). Endemic Tuberculosis Among Homeless Men in New York City. Arch Intern Med 154: 2069-2073 [Abstract]  
• Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., Foresman, B. H. (1994). The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis. NEJM 330: 1179-1184 [Abstract] [Full Text]  
• Bloch, A. B., Cauthen, G. M., Onorato, I. M., Dansbury, K. G., Kelly, G. D., Driver, C. R., Snider, D. E. Jr (1994). Nationwide Survey of Drug-Resistant Tuberculosis in the United States. JAMA 271: 665-671 [Abstract]  
• Iseman, M. D. (1994). Treating Multidrug-Resistant Tuberculosis: Compliance and Side Effects-Reply. JAMA 271: 105-105 [Abstract]  
• Chaulk, C. P., Chaisson, R. E., Lewis, J. N., Rizzo, R. T. (1994). Treating Multidrug-Resistant Tuberculosis: Compliance and Side Effects. JAMA 271: 103-104 [Abstract]  
• Iseman, M. D. (1993). Treatment of Multidrug-Resistant Tuberculosis. NEJM 329: 784-791 [Full Text]  
• Hotchkiss, R. L., DiFerdinando, G. T., Klein, S. J., Novick, L. F., Perlman, D. C., Salomon, N., Iseman, M. D., Cohn, D. L., Sbarbaro, J. A. (1993). Directly Observed Treatment of Tuberculosis. NEJM 329: 135-136 [Full Text]  
• (1993). MORE ON DRUG-RESISTANT TUBERCULOSIS. JWatch General 1993: 3-3 [Full Text]  
• Annas, G. J. (1993). Control of Tuberculosis -- The Law and the Public's Health. NEJM 328: 585-588 [Full Text]